Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Forecasted Federal grant Posted
- Opportunity number
- FOR-FD-25-011
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Applications expected due
- Not on record
- Award size
- $1,000,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Categories
-
- Consumer Protection
- Agriculture
- Food and Nutrition
- Eligible applicants
-
- Special District Governments
- Tribal Governments (Federally Recognized)
- City/Township Governments
- 501(c)(3) Nonprofits
- Small Businesses
- Unrestricted
- Independent School Districts
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Public)
- Higher Education Inst. (Private)
- State Governments
- Public or Indian Housing Auth.
- Tribal Organizations (Not Federally Recognized)
- For Profit Organizations
- County Governments
- Points of contact
-
- Terrin Brown terrin.brown@fda.hhs.gov (240) 402-7610
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Food and Drug Administration is soliciting applications for the Health Equity Innovation Award: Enhance Equity Funding Opportunity under CFDA 93.103 (Food and Drug Administration Research), awarding through cooperative agreement; this is a forecast notice with no application deadline specified in the source. Clinical trials are not permitted. The funding opportunity is unrestricted in eligible applicant types, accepting special district governments, tribal governments (federally recognized), city and township governments, 501(c)(3) and non-501(c)(3) nonprofits, small businesses, independent school districts, higher education institutions (public and private), state governments, public or Indian housing authorities, tribal organizations (not federally recognized), and for-profit organizations.
The program aims to fund innovative research strengthening minority health and health equity objectives across three priority areas: advancing equity in clinical trials by supporting diversity enrollment efforts; equitable data efforts that increase data availability on diverse populations including ethnicity, race, age, disability, and geography; and equity of voices through improved understanding of diverse patient perspectives, preferences, and unmet needs. No cost-share requirement is stated in the source. Award ceiling, award floor, and expected number of awards are not specified. Period of performance and place of performance are not detailed in the source.
The FDA positions this opportunity within its broader Food and Drug Administration Research program, which has averaged 90 to 167 awards annually over the past five years and maintains a portfolio predominantly composed of cooperative agreements (58 percent of awards historically). The program has obligated $4.17 billion across 3,008 grants with an additional $220 million in non-federal cost-share contributions.
Forecast synopsis
The purpose of this notice of funding opportunity (NOFO) is to fund innovative research that will strengthen and advance minority health and health equity objectives.
Areas of interest include:
Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity